Drawing for HCM

USPTO serial 88787147

HCM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
COLTON, BRITTANY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HCM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julianne Abelman

Julianne Abelman Womble Bond Dickinson (US) LLP950 3rd Avenue, Suite 2400New York, NY 10022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicinal, pharmaceutical and veterinary preparations for use in the treatment of cancer, gastrointestinal diseases, diseases affecting the internal organs and immune systems; digestive preparations for medical use; medicinal herbal preparations; herbal supplements; health food supplements; Nutritional food additives for medicinal purposes in the nature of natural food extracts derived from plants; Chinese medicinal preparations for use in the treatment of cancer, immune system diseases, cardiovascular diseases, gastrointestinal diseases, cold and flu, and management of blood lipids; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Dietetic preparations in the nature of herbal extracts adapted for medical purposes; Dietetic foods, namely, soup adapted for medical use; dietetic beverages adapted for medicinal purposes; Biological preparations for the treatment of cancer and heart disease; dietetic food preparations, namely, soup, syrup, confectionery adapted for medical use; baby food; infant food; medicinal oils; edible fish oils for medical purposes, namely, fish oils, cod liver oil, tuna oil, evening primrose oil, micro-encapsulated fish oils, emulsified fish oil, all for medical purposes, in capsule and tablet formACTIVE—
035Retail store services provided on-line from a computer database and the Internet and retail store services, all featuring medicinal and pharmaceutical preparations, digestive preparations, herbal preparations and supplements, Chinese medicines, vitamin and mineral preparations and supplements, dietetic substances, dietetic food and beverages adapted for medicinal purposes, biological and dietetic food preparations for medicinal purposes, health food supplements, and food additives for medicinal purposes, baby and infant food, medicinal oils, fish oils for medicinal purposes, cod liver oil for medicinal purposes, tuna oil for medicinal purposes, evening primrose oil for medicinal purposes, micro-encapsulated oils for medicinal purposes, emulsified oil for medicinal purposes, nutritional and dietetic substances in capsule or tablet form for medicinal purposes; advertising agency services; providing business information; promotion and marketing services; business management and advisory services, namely, assisting business in the formation of business plans and policies relating to medicine, personal health, diet and nutrition; business advisory and consultancy services; franchising services, namely, consultancy and assistance in business management, organization and promotion; Prescription services, namely, providing retail pharmacy servicesACTIVE—
042Medical research in the diagnosis and treatment of heart disease, skin conditions, bone disease, diabetes, cancer, memory loss, osteoporosis, arthritis, dementia, hepatitis, blood diseases, gastrointestinal diseases, diseases affecting the internal organs, nervous system, respiratory system and immune systems; providing specific medical and scientific research information in the field of pharmaceutical products, herbal preparations, Chinese medicines, dietetic substances, on-line and by the Internet to customers upon request; providing temporary use of non-downloadable software over the Internet for tracking documents and for providing information in the field of pharmaceutical products, herbal preparations, Chinese medicines, dietetic substancesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 6, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 5, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 20, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 20, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 20, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 20, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 9, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 9, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 9, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jun 9, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 9, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 9, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 9, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 4, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 2, 2022EX2GSOU EXTENSION 2 GRANTED—
Feb 2, 2022EXT2SOU EXTENSION 2 FILED—
Feb 2, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 4, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 2, 2021EX1GSOU EXTENSION 1 GRANTED—
Aug 2, 2021EXT1SOU EXTENSION 1 FILED—
Aug 2, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 2, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 8, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 8, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 18, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 4, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 14, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 14, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 13, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 13, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2020DOCKASSIGNED TO EXAMINER—
Feb 11, 2020MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 10, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 10, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance